Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456696) titled 'An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Transcend Therapeutics
Condition:
Post Traumatic Stress Disorder
Intervention:
Drug: TSND-201
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: March 2026
Target Sample Size: 300
Countries of Recruitment:
United States
To know more, visit https://c...